For: | Nappo G, Donisi G, Zerbi A. Borderline resectable pancreatic cancer: Certainties and controversies. World J Gastrointest Surg 2021; 13(6): 516-528 [PMID: 34194610 DOI: 10.4240/wjgs.v13.i6.516] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v13/i6/516.htm |
Number | Citing Articles |
1 |
Marco Massani, Tommaso Stecca. Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1138587
|
2 |
Luis Marti-Bonmati, Leonor Cerdá-Alberich, Alexandre Pérez-Girbés, Roberto Díaz Beveridge, Eva Montalvá Orón, Judith Pérez Rojas, Angel Alberich-Bayarri. Pancreatic cancer, radiomics and artificial intelligence. The British Journal of Radiology 2022; 95(1137) doi: 10.1259/bjr.20220072
|
3 |
Anna Silvia Wenning, Christoph O. Ryser, Andreas Andreou, Beat Gloor, Martin D. Berger. Neues zur Therapie des Pankreaskarzinoms: Hoffnung am Horizont?. Schweizer Gastroenterologie 2021; 2(4): 138 doi: 10.1007/s43472-021-00054-y
|
4 |
Gunjan Desai, Prasad K. Wagle. First jejunal vein, jejunal trunk, and pancreatico-duodenectomy: resolving the literature conundrum. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-02849-w
|
5 |
Alessandro Cucchetti, Stefano Crippa, Elton Dajti, Cecilia Binda, Carlo Fabbri, Massimo Falconi, Giorgio Ercolani. Trial sequential analysis of randomized controlled trials on neoadjuvant therapy for resectable pancreatic cancer. European Journal of Surgical Oncology 2022; 48(9): 1994 doi: 10.1016/j.ejso.2022.04.011
|